AnaptysBio, Inc.
ANAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $110 | $44 | $99 | $123 |
| Short-Term Investments | $139 | $221 | $241 | $262 |
| Receivables | $76 | $21 | $18 | $41 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $5 | $5 | $6 |
| Total Curr. Assets | $331 | $292 | $363 | $432 |
| Property Plant & Equip (Net) | $14 | $15 | $16 | $16 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $8 | $28 | $43 | $35 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $22 | $43 | $59 | $52 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $353 | $335 | $422 | $484 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $6 | $4 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4 | $0 |
| Other Curr. Liab. | $33 | $30 | $32 | $40 |
| Total Curr. Liab. | $38 | $36 | $44 | $45 |
| LT Debt | $344 | $13 | $14 | $14 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $331 | $330 | $353 |
| Total NC Liab. | $344 | $344 | $344 | $368 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $15 | $16 | $16 |
| Total Liabilities | $383 | $380 | $388 | $413 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$822 | -$837 | -$799 | -$759 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $793 | $793 | $832 | $830 |
| Total Equity | -$29 | -$45 | $34 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $353 | $335 | $422 | $484 |
| Net Debt | $237 | -$29 | -$83 | -$107 |